Pawel Marcin Wisniewski
Director/Board Member en PURE BIOLOGICS S.A. .
Perfil
Pawel Marcin Wisniewski is currently serving as the Vice Chairman-Management Board at Helix Immuno-Oncology SA. He is also the Deputy Chairman-Supervisory Board at Pure Biologics SA and the Vice President-Management Board at 4cell Therapies SA. Previously, he held the position of Chief Executive Officer at Helix Polska Sp zoo and worked as a Project Manager at Adiuvo Investments SA from 2012 to 2016.
Cargos activos de Pawel Marcin Wisniewski
Empresas | Cargo | Inicio |
---|---|---|
PURE BIOLOGICS S.A. | Director/Board Member | 26/05/2023 |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Pawel Marcin Wisniewski.
Empresas | Cargo | Fin |
---|---|---|
Helix Polska Sp zoo
Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland. | Chief Executive Officer | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PURE BIOLOGICS S.A. | Health Technology |
Empresas privadas | 2 |
---|---|
Helix Polska Sp zoo
Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland. | Health Technology |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Health Technology |
- Bolsa de valores
- Insiders
- Pawel Marcin Wisniewski